Jane Henderson

Jane Pritchett V.
Henderson is currently Executive Director at Dedman College of Humanities & Sciences, Director at Ventus Therapeutics U.S., Inc. since 2021, Secretary & Treasurer at The EQUUS Foundation, Inc., and Chief Financial Officer at Apogee Therapeutics, Inc. since 2023.
Former positions include Managing Director at CIBC World Markets Corp.
(2001-2005), Managing Director at Canadian Imperial Bank of Commerce, HSBC Holdings Plc, HSBC Securities (USA), Inc., and Salomon Brothers; Independent Director at IVERIC bio, Inc. (2018-2023), Sesen Bio, Inc. (2013-2021), Akero Therapeutics, Inc. (2019-2025), and Cargo Therapeutics, Inc. (2024-2025); Senior Vice President at Lehman Brothers, Inc. (1999-2001); Vice President-Business Development at ISTA Pharmaceuticals, Inc. (2010-2012); Senior VP, Chief Financial & Business Officer at Kolltan Pharmaceuticals, Inc. (2014-2016); CFO, Executive VP & Chief Business Officer at Renetx Bio, Inc. (2009-2010); CFO, Secretary, Chief Business Officer & EVP at Panacos Pharmaceuticals, Inc. (2008-2009); CFO & Senior VP-Corporate Development at Voyager Therapeutics, Inc. (2017-2018); CFO & Head-Business Development at Axerion Pharmaceuticals, Inc. (2009-2010); Chief Financial Officer at Turnstone Biologics Corp.
(2018-2020); Chief Financial & Business Officer at Invivyd, Inc. (2022); and Director at Ventus Therapeutics, Inc. Education includes undergraduate studies at Duke University.